文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

儿科撤机:555名国际儿科重症医师的实践调查

Pediatric Ventilation Liberation: A Survey of International Practice Among 555 Pediatric Intensivists.
PubMed 文献 · Crit Care Explor · 2022-09-02
一句话结论国际儿科撤机实践高度异质:86.4%采用撤机后SBT,SBT压力支持多用+10 cm H2O,HFNC与NIV计划撤机后使用比例多数报告≤50%与≤20%。

该国际横断面电子调查纳入47个国家的555名非培训期儿科医疗与心脏重症医师,描述儿科撤机实践及地区差异。多数受访者报告先撤机再行SBT(86.4%);SBT资格变量以PEEP(95%)、FiO2(93.4%)、峰值吸气压力(73.9%)居前;SBT压力支持40.4%报告使用标准化压力支持而不论气管导管尺寸,其中+10 cm H2O占主导(38.6%);SBT时长≤30分钟34.8%、31分钟至1小时39.3%、>1小时26%。计划HFNC用于≤50%拔管者占83.2%,计划NIV用于≤20%拔管者占79.9%。结论认为国际实践异质,未来需研究填补关键证据缺口,地区因素需在国际研究设计中考虑。

要点

  • 多数受访者(86.4%)报告采用先撤机再行SBT的流程。
  • SBT资格前三位变量:PEEP(95%)、FiO2(93.4%)、峰值吸气压力(73.9%)。
  • SBT压力支持40.4%报告使用标准化水平而不论气管导管尺寸,其中+10 cm H2O占38.6%。
  • SBT时长分布:≤30分钟34.8%、31分钟至1小时39.3%、>1小时26%。
  • 计划HFNC用于≤50%拔管者占83.2%;计划NIV用于≤20%拔管者占79.9%。

适用人群与场景

  • 国际横断面电子调查,对象为非培训期儿科医疗与心脏重症监护医师。
  • 555份回复,代表47个国家。

诊断标准与关键阈值

  • SBT资格变量前三位:PEEP(95%)、FiO2(93.4%)、峰值吸气压力(73.9%)。
  • 判定SBT结果的前三位变量:呼吸频率(94%)、氧饱和度(89.3%)、主观呼吸做功(79.8%)。

处置流程与药物剂量

  • 多数受访者(86.4%)报告采用先撤机再行SBT的流程。
  • SBT压力支持:40.4%报告使用标准化压力支持而不论气管导管尺寸,其中+10 cm H2O占38.6%。
  • SBT时长:≤30分钟占34.8%,31分钟至1小时占39.3%,>1小时占26%。
  • 拔管准备集束元素:频繁考虑气管内分泌物负荷(81.3%)、标准化疼痛/镇静评估(72.8%)、液体平衡(83%)、气管漏气试验。
  • 计划HFNC:多数报告用于≤50%的拔管(83.2%);支持子人群前三位为慢性肺病(67.3%)、有创通气>14天(66.6%)、慢性危重症(44.9%)。
  • 计划NIV:多数报告用于≤20%的拔管(79.9%);支持子人群前三位为神经肌肉疾病(72.8%)、慢性肺病(66.7%)、因任何原因长期使用NIV(61.6%)。

研究设计与关键结果

  • 研究类型:国际横断面电子调查;样本量555份回复,代表47个国家;人群为非培训期儿科医疗与心脏重症医师。
  • 主要结局:描述儿科撤机实践及地区差异;86.4%报告先撤机再行SBT。
  • SBT资格变量:PEEP 95%、FiO2 93.4%、峰值吸气压力73.9%。
  • SBT压力支持:标准化压力支持而不论气管导管尺寸占40.4%,+10 cm H2O占38.6%。
  • SBT时长:≤30分钟34.8%、31分钟至1小时39.3%、>1小时26%。
  • SBT结果判定变量:呼吸频率94%、氧饱和度89.3%、主观呼吸做功79.8%。
  • 拔管准备集束:气管内分泌物负荷81.3%、标准化疼痛/镇静评估72.8%、液体平衡83%、气管漏气试验。
  • 计划HFNC用于≤50%拔管者83.2%;子人群:慢性肺病67.3%、有创通气>14天66.6%、慢性危重症44.9%。

证据类型、等级与局限

  • 证据类型:国际横断面电子调查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 调查显示国际儿科撤机实践高度异质,SBT资格、压力支持水平、时长及拔管后呼吸支持策略差异大,地区因素是重要变异来源。
  • 作者认为未来需研究填补关键证据缺口,国际研究设计需考虑受访者地区差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Pediatric ventilation liberation has limited evidence, likely resulting in wide practice variation. To inform future work, practice patterns must first be described.

OBJECTIVES: Describe international pediatric ventilation liberation practices and regional practice variation.

DESIGN SETTING AND PARTICIPANTS: International cross-sectional electronic survey. Nontrainee pediatric medical and cardiac critical care physicians.

MAIN OUTCOMES AND MEASURES: Practices focusing on spontaneous breathing trial (SBT) eligibility, SBT practice, non-SBT extubation readiness bundle elements, and post-extubation respiratory support.

RESULTS: Five-hundred fifty-five responses representing 47 countries were analyzed. Most respondents reported weaning followed by an SBT (86.4%). The top SBT eligibility variables reported were positive end-expiratory pressure (95%), Fio2 (93.4%), and peak inspiratory pressure (73.9%). Most reported use of standardized pressure support regardless of endotracheal tube size (40.4%) with +10 cm H2O predominating (38.6%). SBT durations included less than or equal to 30 minutes (34.8%), 31 minutes to 1 hour (39.3%), and greater than 1 hours (26%). In assigning an SBT result, top variables were respiratory rate (94%), oxygen saturation (89.3%), and subjective work of breathing (79.8%). Most reported frequent consideration of endotracheal secretion burden (81.3%), standardized pain/sedation measurement (72.8%), fluid balance (83%), and the endotracheal air leak test as a part of extubation readiness bundles. Most reported using planned high flow nasal cannula in less than or equal to 50% of extubations (83.2%). Top subpopulations supported with planned HFNC were those with chronic lung disease (67.3%), exposed to invasive ventilation greater than 14 days (66.6%), and chronic critical illness (44.9%). Most reported using planned noninvasive ventilation (NIV) following less than or equal to 20% of extubations (79.9%). Top subpopulations supported with planned NIV were those with neuromuscular disease (72.8%), chronic lung disease (66.7%), and chronic NIV use for any reason (61.6%). Regional variation was high for most practices studied.

CONCLUSION AND RELEVANCE: International pediatric ventilation liberation practices are heterogeneous. Future study is needed to address key evidence gaps. Many practice differences were associated with respondent region, which must be considered in international study design.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Loberger JM, Campbell CM, Colleti J, et al. Pediatric Ventilation Liberation: A Survey of International Practice Among 555 Pediatric Intensivists. Crit Care Explor. 2022. PMID: 36082374. doi:10.1097/CCE.0000000000000756

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。